Valsartan 80 MG Oral Tablet — RxCUI 349199
RxNorm drug concept · Semantic clinical drug
RxCUI 349199
Semantic clinical drug · SCD
● Current RxNorm concept 108 FDA products
302 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI349199
Official nameValsartan 80 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped108
Package NDCs mapped302
Reported Medicaid activity (SDUD)609,688 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Valsartan: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Valsartan is a blood pressure-lowering medication. It's most commonly used to treat high blood pressure, but it's also prescribed for heart failure and to reduce the risk of dying...
- Yes — valsartan tablets can be taken with or without food, so take it whichever way works best for you. Just try to take it at the same time each day to keep your blood levels stea...
- Can I take valsartan with or without food?
- The most common ones are headache, dizziness, tiredness, and stomach pain — these are usually mild. The ones that need a call to your doctor are more serious: feeling faint or actu...
🕸️ Concept Web — How Valsartan 80 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Valsartan 80 MG Oral Tablet
RxCUI 349199 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Valsartan
69749IN
-
Valsartan
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Diovan
216652BN
-
Diovan
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Valsartan Oral Tablet
378276SCDF -
Valsartan Oral Product
1163997SCDG -
Valsartan Pill
1164561SCDG -
Valsartan Oral Tablet [Diovan]
368070SBDF -
Diovan Oral Product
1171720SBDG -
Diovan Pill
1171721SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Valsartan Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Valsartan 80 MG
316882SCDC -
Valsartan 80 MG Oral Tablet [Diovan]
351761SBD -
Valsartan 80 MG [Diovan]
565166SBDC
-
Valsartan 80 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Valsartan 80 MG
SCDC · 316882 -
Valsartan Oral Tablet
SCDF · 378276 -
Valsartan Oral Product
SCDG · 1163997 -
Valsartan Pill
SCDG · 1164561
Brand-Name Concepts
-
Valsartan 80 MG Oral Tablet [Diovan]
SBD · 351761 -
Valsartan 80 MG [Diovan]
SBDC · 565166 -
Valsartan Oral Tablet [Diovan]
SBDF · 368070 -
Diovan Oral Product
SBDG · 1171720 -
Diovan Pill
SBDG · 1171721 -
Diovan
BN · 216652
📦 FDA Products & Package NDCs
108 products · 302 package NDCs
302 package NDCs map to RxCUI 349199 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 65862-0573-90 | 90 TABLET, FILM COATED in 1 BOTTLE (65862-573-90) | Valsartan | Aurobindo Pharma Limited | 2015-01-05 |
| 67877-0415-05 | 500 TABLET, FILM COATED in 1 BOTTLE (67877-415-05) | Valsartan | Ascend Laboratories, LLC | 2019-03-14 |
| 67877-0415-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (67877-415-10) | Valsartan | Ascend Laboratories, LLC | 2019-03-14 |
| 67877-0415-30 | 30 TABLET, FILM COATED in 1 BOTTLE (67877-415-30) | Valsartan | Ascend Laboratories, LLC | 2019-03-14 |
| 67877-0416-05 | 500 TABLET, FILM COATED in 1 BOTTLE (67877-416-05) | Valsartan | Ascend Laboratories, LLC | 2019-03-14 |
| 67877-0416-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (67877-416-10) | Valsartan | Ascend Laboratories, LLC | 2019-03-14 |
| 67877-0416-90 | 90 TABLET, FILM COATED in 1 BOTTLE (67877-416-90) | Valsartan | Ascend Laboratories, LLC | 2019-03-14 |
| 67877-0417-05 | 500 TABLET, FILM COATED in 1 BOTTLE (67877-417-05) | Valsartan | Ascend Laboratories, LLC | 2019-03-14 |
| 67877-0417-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (67877-417-10) | Valsartan | Ascend Laboratories, LLC | 2019-03-14 |
| 67877-0417-90 | 90 TABLET, FILM COATED in 1 BOTTLE (67877-417-90) | Valsartan | Ascend Laboratories, LLC | 2019-03-14 |
| 67877-0418-05 | 500 TABLET, FILM COATED in 1 BOTTLE (67877-418-05) | Valsartan | Ascend Laboratories, LLC | 2019-03-14 |
| 67877-0418-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (67877-418-10) | Valsartan | Ascend Laboratories, LLC | 2019-03-14 |
| 67877-0418-90 | 90 TABLET, FILM COATED in 1 BOTTLE (67877-418-90) | Valsartan | Ascend Laboratories, LLC | 2019-03-14 |
| 70771-1882-03 | 30 TABLET, FILM COATED in 1 BOTTLE (70771-1882-3) | Valsartan | Zydus Lifesciences Limited | 2024-08-30 |
| 70771-1883-09 | 90 TABLET, FILM COATED in 1 BOTTLE (70771-1883-9) | Valsartan | Zydus Lifesciences Limited | 2024-08-30 |
| 70771-1884-09 | 90 TABLET, FILM COATED in 1 BOTTLE (70771-1884-9) | Valsartan | Zydus Lifesciences Limited | 2024-08-30 |
| 70771-1885-09 | 90 TABLET, FILM COATED in 1 BOTTLE (70771-1885-9) | Valsartan | Zydus Lifesciences Limited | 2024-08-30 |
| 71335-0567-01 | 30 TABLET in 1 BOTTLE (71335-0567-1) | Valsartan | Bryant Ranch Prepack | 2023-11-22 |
| 71335-0567-02 | 90 TABLET in 1 BOTTLE (71335-0567-2) | Valsartan | Bryant Ranch Prepack | 2023-11-22 |
| 71335-0567-03 | 60 TABLET in 1 BOTTLE (71335-0567-3) | Valsartan | Bryant Ranch Prepack | 2023-11-22 |
| 71335-0567-04 | 28 TABLET in 1 BOTTLE (71335-0567-4) | Valsartan | Bryant Ranch Prepack | 2023-11-22 |
| 71335-2152-01 | 30 TABLET, FILM COATED in 1 BOTTLE (71335-2152-1) | Valsartan | Bryant Ranch Prepack | 2022-08-22 |
| 71335-2152-02 | 90 TABLET, FILM COATED in 1 BOTTLE (71335-2152-2) | Valsartan | Bryant Ranch Prepack | 2022-08-22 |
| 71335-2152-03 | 60 TABLET, FILM COATED in 1 BOTTLE (71335-2152-3) | Valsartan | Bryant Ranch Prepack | 2022-08-22 |
| 71335-2152-04 | 28 TABLET, FILM COATED in 1 BOTTLE (71335-2152-4) | Valsartan | Bryant Ranch Prepack | 2022-08-22 |
| 72189-0049-60 | 60 TABLET, FILM COATED in 1 BOTTLE (72189-049-60) | VALSARTAN | Direct_Rx | 2019-10-08 |
| 72189-0550-30 | 30 TABLET, FILM COATED in 1 BOTTLE (72189-550-30) | Valsartan | Direct_Rx | 2024-04-26 |
| 72578-0131-06 | 30 TABLET, FILM COATED in 1 BOTTLE (72578-131-06) | Valsartan | Viona Pharmaceuticals Inc | 2024-08-30 |
| 72578-0132-16 | 90 TABLET, FILM COATED in 1 BOTTLE (72578-132-16) | Valsartan | Viona Pharmaceuticals Inc | 2024-08-30 |
| 72578-0133-16 | 90 TABLET, FILM COATED in 1 BOTTLE (72578-133-16) | Valsartan | Viona Pharmaceuticals Inc | 2024-08-30 |
| 72578-0134-16 | 90 TABLET, FILM COATED in 1 BOTTLE (72578-134-16) | Valsartan | Viona Pharmaceuticals Inc | 2024-08-30 |
| 76483-0023-00 | 30 TABLET in 1 BOTTLE (76483-023-00) | Valsartan | SQUARE PHARMACEUTICALS LIMITED | 2022-07-15 |
| 76483-0023-03 | 90 TABLET in 1 BOTTLE (76483-023-03) | Valsartan | SQUARE PHARMACEUTICALS LIMITED | 2022-07-15 |
| 76483-0023-04 | 100 TABLET in 1 BOTTLE (76483-023-04) | Valsartan | SQUARE PHARMACEUTICALS LIMITED | 2022-07-15 |
| 76483-0023-05 | 500 TABLET in 1 BOTTLE (76483-023-05) | Valsartan | SQUARE PHARMACEUTICALS LIMITED | 2022-07-15 |
| 76483-0023-06 | 1000 TABLET in 1 BOTTLE (76483-023-06) | Valsartan | SQUARE PHARMACEUTICALS LIMITED | 2022-07-15 |
| 76483-0024-00 | 30 TABLET in 1 BOTTLE (76483-024-00) | Valsartan | SQUARE PHARMACEUTICALS LIMITED | 2022-07-15 |
| 76483-0024-03 | 90 TABLET in 1 BOTTLE (76483-024-03) | Valsartan | SQUARE PHARMACEUTICALS LIMITED | 2022-07-15 |
| 76483-0024-04 | 100 TABLET in 1 BOTTLE (76483-024-04) | Valsartan | SQUARE PHARMACEUTICALS LIMITED | 2022-07-15 |
| 76483-0024-05 | 500 TABLET in 1 BOTTLE (76483-024-05) | Valsartan | SQUARE PHARMACEUTICALS LIMITED | 2022-07-15 |
| 76483-0024-06 | 1000 TABLET in 1 BOTTLE (76483-024-06) | Valsartan | SQUARE PHARMACEUTICALS LIMITED | 2022-07-15 |
| 76483-0025-00 | 30 TABLET in 1 BOTTLE (76483-025-00) | Valsartan | SQUARE PHARMACEUTICALS LIMITED | 2022-07-15 |
| 76483-0025-03 | 90 TABLET in 1 BOTTLE (76483-025-03) | Valsartan | SQUARE PHARMACEUTICALS LIMITED | 2022-07-15 |
| 76483-0025-04 | 100 TABLET in 1 BOTTLE (76483-025-04) | Valsartan | SQUARE PHARMACEUTICALS LIMITED | 2022-07-15 |
| 76483-0025-05 | 500 TABLET in 1 BOTTLE (76483-025-05) | Valsartan | SQUARE PHARMACEUTICALS LIMITED | 2022-07-15 |
| 76483-0025-06 | 1000 TABLET in 1 BOTTLE (76483-025-06) | Valsartan | SQUARE PHARMACEUTICALS LIMITED | 2022-07-15 |
| 76483-0026-00 | 30 TABLET in 1 BOTTLE (76483-026-00) | Valsartan | SQUARE PHARMACEUTICALS LIMITED | 2022-07-15 |
| 76483-0026-03 | 90 TABLET in 1 BOTTLE (76483-026-03) | Valsartan | SQUARE PHARMACEUTICALS LIMITED | 2022-07-15 |
| 76483-0026-04 | 100 TABLET in 1 BOTTLE (76483-026-04) | Valsartan | SQUARE PHARMACEUTICALS LIMITED | 2022-07-15 |
| 76483-0026-05 | 500 TABLET in 1 BOTTLE (76483-026-05) | Valsartan | SQUARE PHARMACEUTICALS LIMITED | 2022-07-15 |
Observed labelers:
Camber Pharmaceuticals, Inc. (40) ·
Dr. Reddy's Laboratories Limited (22) ·
SQUARE PHARMACEUTICALS LIMITED (20) ·
Alembic Pharmaceuticals Inc. (19) ·
Alembic Pharmaceuticals Limited (19) ·
Jubilant Cadista Pharmacuticals Inc. (16)
· +22 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.